Skip to content
DraconiticResearch
Search Sources API
186,123 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BY-NCEuropean journal of neurology

Progressive Amyloid‐Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier

  • Elisabeth Stögmann1
  • Lukas Haider1
  • Joel Leinkauf1
  • Thomas Nakuz1
  • Helena Untersteiner1
  • Clemens Farr1
  • Sara Silvaieh1
  • Tandis Parvizi1
  • Raphael Wurm1
  • Gregor Kasprian1
  • Thomas Berger1
  • Ellen Gelpi1
1 more authors
  • Evelyn Berger Sieczkowski1
  1. 1Medical University of Vienna
Read full textPDFCite

Related

  1. Utilisation du lecanemab au stade précoce de la maladie d’Alzheimer au Canada.
    Sophie M Weiss, Jennifer A Watt, Vivian Ewa +1
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadiennePeer-reviewedCC BY-NC-NDFull textPhysiologyEurope PMC
  2. Efficacy and safety of lecanemab monoclonal antibody in the treatment of mild to moderate Alzheimer’s disease: a systematic review and meta-analysis
    Shang-Ying Li, Jia-Xin Zhang, Long-Zhuan Huang +5
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Estimating the eligible population for amyloid-targeting monoclonal antibody therapy in memory clinics: Application to lecanemab in France.
    Lisa Le Scouarnec, Vincent Bouteloup, Leslie Grasset +4
    The journal of prevention of Alzheimer's diseasePeer-reviewedCC BY-NC-NDFull textPhysiologyEurope PMC
  4. Cost‐effectiveness of lecanemab for early Alzheimer's disease in China
    Xingguang Zhao, Mingsong Xu, Hualin Chen +4
    Alzheimer's & DementiaPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  5. Drug-Drug Interaction Signals Between Anti-Amyloid-β Antibodies and Antithrombotic Drugs for Amyloid-Related Imaging Abnormalities and Intracranial Hemorrhage: A FAERS Disproportionality Analysis
    T. Nakai, T. Koseki, H. Watanabe +1
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv

Cite

BibTeXRIS
BibTeX
@article{stogmann2026progressive,
  title = {{Progressive Amyloid‐Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier}},
  author = {Elisabeth Stögmann and Lukas Haider and Joel Leinkauf and Thomas Nakuz and Helena Untersteiner and Clemens Farr and Sara Silvaieh and Tandis Parvizi and Raphael Wurm and Gregor Kasprian and Thomas Berger and Ellen Gelpi and Evelyn Berger Sieczkowski},
  journal = {European journal of neurology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13656894},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Progressive Amyloid‐Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier
AU  - Elisabeth Stögmann
AU  - Lukas Haider
AU  - Joel Leinkauf
AU  - Thomas Nakuz
AU  - Helena Untersteiner
AU  - Clemens Farr
AU  - Sara Silvaieh
AU  - Tandis Parvizi
AU  - Raphael Wurm
AU  - Gregor Kasprian
AU  - Thomas Berger
AU  - Ellen Gelpi
AU  - Evelyn Berger Sieczkowski
PY  - 2026
DA  - 2026/10/01
JO  - European journal of neurology
UR  - https://europepmc.org/article/PMC/PMC13656894
SN  - 1351-5101
SN  - 1468-1331
ER  -